Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

SANA Q4 2019 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$845M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$45M

Net Income

-$43M

EPS (Diluted)

$-0.27

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$40M

Stock-Based Comp.

$487,000

Balance Sheet

Total Assets

$415M

Total Liabilities

$558M

Stockholders' Equity

-$143M

Cash & Equivalents

$80M

← FY 2019 All Quarters Q1 2020 →